-+ 0.00%
-+ 0.00%
-+ 0.00%

ENLIVEN THERAPEUTICS, INC. : JP MORGAN INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $75

Reuters·10/01/2026 04:23:02